CVS HEALTH (CVS) Stock: Buy, Sell, or Hold?
CVS - CVS HEALTH CORPORATION
$86.16
-1.64 (-1.87%)
▼
5d:
-0.35%
30d:
-9.58%
90d:
-18.64%
HOLD
LOW Confidence
Analysis Updated: Oct 9, 2026 12:00 AM ET
Earnings: Nov 04, 2026
22d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Oct 5, 2026 at $87.01 · last confirmed Oct 9, 2026
Strength: 7.0/10
Get Alerted When CVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CVS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CVS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$117.90
Based on 5.1% avg growth
INTRINSIC VALUE TODAY
$73.21
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CVS is currently trading at $86.16, which is considered oversold relative to its 30-day fair value range of $86.23 to $94.96. The stock's valuation (Forward PE: 10.1) is in line with its historical norms (10.8). Remarkably, the market is currently pricing in an annual earnings decline of 2.2% over the next few years. This pessimistic expectation contrasts with the company's recent 188.8% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CVS is in a downtrend. The price is currently testing key support at $84.23. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CVS scores 82/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $115.76 (+34.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CVS is in a downtrend. The price is currently testing key support at $84.23. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CVS scores 82/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $115.76 (+34.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$86.23 -
$94.96
Company Quality Score
70/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
90.5%
Protect Your Profits
Holding CVS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (82/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 34.4% below Wall St target ($115.76)
- CAUTION: Bottoming setup, but lagging the sector by 15% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$86.23 -
$94.96
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$84.23
Resistance Level
$90.02
Current Trend
Downtrend
Technical data as of
Oct 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.10
Wall Street Target
$115.76
(+34.4%)
Revenue Growth (YoY)
7.1%
Earnings Growth (YoY)
188.8%
Profit Margin
1.2%
Valuation Discount vs History
-2.2% cheaper
PE vs Historical
10.1 vs 10.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.2%
(market-implied from PE analysis)
1-Year Target
$84.26
(-2%)
2-Year Target
$82.41
(-4%)
3-Year Target
$80.60
(-7%)
3-Yr Target (if PE normalizes)
(PE: 10→11)
$86.22
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 6.1%)
$202.50
(+135%)
Base:
(SPY PE: 10.1, Growth: 6.1%)
$102.94
(+20%)
Bear:
(PE: 8.6, Growth: 6.1%)
$87.50
(+2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (23x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 23.11 | Current EPS (TTM): $3.80
Bull Case
$193.16
(+124%)
Analyst growth 100.0%, PE expands to 25.4
Base Case
$175.60
(+104%)
Market implied 100.0%, PE stable at 23.1
Bear Case
$59.70
(-31%)
Severe decline -20.0%, PE contracts to 19.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.1 to 10.8
Stabilization Target:
$92.17
(+7.0%)
PE Expansion Potential:
+7.0%
Share & Embed Analysis
Last updated: October 12, 2026 3:56 AM ET
Data refreshes hourly during market hours. Next update: 4:56 AM
Data refreshes hourly during market hours. Next update: 4:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CVS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
26 analysts |
$482 | 58 HOLD |
|
CI
Cigna Corp |
STRONG BUY
24 analysts |
$342 | 54 HOLD |
|
ELV
Elevance Health Inc |
BUY
22 analysts |
$451 | 54 HOLD |
|
HUM
Humana Inc |
BUY
26 analysts |
$453 | 40 HOLD |
|
ALHC
Alignment Healthcare LLC |
STRONG BUY
14 analysts |
$17 | 45 HOLD |
Advanced CVS Option Strategies
Professional options setups generated by AI based on today's CVS price and gamma walls.
